Opioid Atlas: Mapping Access to Pain Medication
Kris Sankaran, Suzanne Tamang, Ami Bhatt

TL;DR
The paper introduces the Opioid Atlas, a visualization tool that maps global access to pain-relief opioids, revealing geographic disparities and aiding policymakers and researchers in understanding factors influencing opioid availability.
Contribution
It presents a novel data visualization platform for analyzing country-level opioid consumption data, integrating multivariate analysis techniques to explore geographic disparities.
Findings
Identifies significant geographic variation in opioid access.
Provides a publicly available tool for policymakers and researchers.
Facilitates systematic assessment of factors affecting opioid distribution.
Abstract
Opiates are some of the most effective pain relief medications available for patients suffering from cancer and surgery-related pain. Despite the affordability and effectiveness of these medications, access to opiates is highly geographically variable. Pain researchers have attributed geographic variation to various factors including the fear of opioid addiction, diversion of legal opiods to the underground market and pharmaceutical industry influences. However, the extent to which there is inequity in untreated cancer and surgery-related pain is unknown. To help opioid investigators study these questions, we designed a tool, the Opioid Atlas, for exploring data on legal opioid consumption, by country and time, collected by the International Narcotics Control Board. Our design borrows ideas from the data visualization and multivariate statistics communities, especially the principles of…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsOpioid Use Disorder Treatment · Pharmaceutical Practices and Patient Outcomes · Health Systems, Economic Evaluations, Quality of Life
